Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Spaventa currently holds 4,374 shares of Singular Genomics Systems, Inc. (OMIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Spaventa has been a net buyer of OMIC stock. They have purchased $49.3K and sold $2.2K worth of shares.
Andrew Spaventa's most recent insider trade was on Dec 15, 2024, when they sold 486 shares at $0.00 per share.
Andrew Spaventa serves as Executive at Singular Genomics Systems, Inc. (OMIC). They have executed 43 insider transactions totaling $51.5K over their tenure at the company.
Andrew Spaventa holds the position of Executive at Singular Genomics Systems, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Andrew Spaventa has shown a buying trading pattern, with $49.3K in total purchases and $2.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Andrew Spaventa was on Jun 1, 2021, when they sold $3.0M worth of OMIC shares. This transaction involved 173,144 shares at $17.60 per share.
Andrew Spaventa currently owns 4,374 shares of Singular Genomics Systems, Inc. (OMIC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Spaventa's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Spaventa has 43 Form 4 filings on record as an insider at Singular Genomics Systems, Inc..
Set alerts for Andrew Spaventa and 40,000+ other insiders.